- Home
- GHG vs LUNG Comparison
GHG vs LUNG Comparison
Compare GHG & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- LUNG
- Stock Information
- Founded
- GHG 2004
- LUNG 1995
- Country
- GHG China
- LUNG United States
- Employees
- GHG N/A
- LUNG N/A
- Industry
- GHG Hotels/Resorts
- LUNG Industrial Specialties
- Sector
- GHG Consumer Discretionary
- LUNG Health Care
- Exchange
- GHG Nasdaq
- LUNG Nasdaq
- Market Cap
- GHG 279.2M
- LUNG 299.3M
- IPO Year
- GHG 2018
- LUNG 2020
- Fundamental
- Price
- GHG $2.57
- LUNG $7.35
- Analyst Decision
- GHG
- LUNG Strong Buy
- Analyst Count
- GHG 0
- LUNG 7
- Target Price
- GHG N/A
- LUNG $12.64
- AVG Volume (30 Days)
- GHG 23.9K
- LUNG 269.0K
- Earning Date
- GHG 04-01-2025
- LUNG 04-30-2025
- Dividend Yield
- GHG 3.31%
- LUNG N/A
- EPS Growth
- GHG N/A
- LUNG N/A
- EPS
- GHG 0.28
- LUNG N/A
- Revenue
- GHG $201,166,731.00
- LUNG $83,789,000.00
- Revenue This Year
- GHG N/A
- LUNG $17.96
- Revenue Next Year
- GHG $8.78
- LUNG $18.35
- P/E Ratio
- GHG $9.24
- LUNG N/A
- Revenue Growth
- GHG N/A
- LUNG 22.01
- 52 Week Low
- GHG $2.31
- LUNG $5.46
- 52 Week High
- GHG $3.48
- LUNG $10.01
- Technical
- Relative Strength Index (RSI)
- GHG 45.47
- LUNG 46.66
- Support Level
- GHG $2.46
- LUNG $7.65
- Resistance Level
- GHG $2.83
- LUNG $7.97
- Average True Range (ATR)
- GHG 0.13
- LUNG 0.44
- MACD
- GHG -0.00
- LUNG -0.08
- Stochastic Oscillator
- GHG 33.33
- LUNG 33.04
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.